↓ Skip to main content

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma

Overview of attention for article published in OncoTargets and therapy, October 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
9 X users

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
Published in
OncoTargets and therapy, October 2018
DOI 10.2147/ott.s175016
Pubmed ID
Authors

Marta Garcia-Recio, Jordi Martinez-Serra, Francesc Mestre, Leyre Bento, Jordi Gines, Rafael Ramos, Jaime Daumal, Paloma López, Antonia Sampol, Antonio Gutierrez

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 13%
Other 1 13%
Student > Postgraduate 1 13%
Student > Master 1 13%
Unknown 4 50%
Readers by discipline Count As %
Medicine and Dentistry 2 25%
Biochemistry, Genetics and Molecular Biology 1 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2019.
All research outputs
#6,924,668
of 25,385,509 outputs
Outputs from OncoTargets and therapy
#345
of 3,016 outputs
Outputs of similar age
#115,070
of 354,551 outputs
Outputs of similar age from OncoTargets and therapy
#18
of 138 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.